{
  "casebody": {
    "data": "<casebody firstpage=\"902\" lastpage=\"902\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<parties data-order=\"0\" data-type=\"parties\" id=\"b930-8\">E8 PHARMACEUTICALS, LLC and The Massachusetts Institute of Technology, Plaintiffs-Appellants, v. AFFYMETRIX, INC. and Navigenics, Inc., Defendants-Appellees.</parties>\n<docketnumber data-order=\"1\" data-type=\"docketnumber\" id=\"b930-11\">No. 2013-1046.</docketnumber>\n<court data-order=\"2\" data-type=\"court\" id=\"b930-12\">United States Court of Appeals, Federal Circuit.</court>\n<decisiondate data-order=\"3\" data-type=\"decisiondate\" id=\"b930-13\">Nov. 6, 2013.</decisiondate>\n<attorneys data-order=\"4\" data-type=\"attorneys\" id=\"b930-16\">John B. Wyss, Wiley Rein LLP, of Washington, DC, argued for plaintiffs-appellants. With him on the brief were James H. Wallace, Jr., Mark A. Pacella, and Gregory R. Lyons.</attorneys>\n<attorneys data-order=\"5\" data-type=\"attorneys\" id=\"b930-17\">Peter E. Root, Kaye Scholer LLP, of Palo Alto, CA, argued for defendants-ap-pellees. With him on the brief were Michael J. Malecek, Sean M. Boyle, and Gary Ross Allen.</attorneys>\n<p data-order=\"6\" data-type=\"judges\" id=\"b930-18\">Before LOURIE, DYK, and O\u2019MALLEY, Circuit Judges.</p>\n<opinion data-order=\"7\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<author id=\"b930-19\">PER CURIAM.</author>\n<p id=\"b930-20\">We affirm the judgment of noninfringement in favor of Affymetrix, Inc. and Navi-genics, Inc. We base our decision solely on our agreement with the district court\u2019s construction of the phrase \u201crandomly primed PCR-derived RCG.\u201d We do not reach any other issues raised on appeal.</p>\n<p id=\"b930-21\">AFFIRMED</p>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}